New Treatments for Migraine

Update Item Information
Identifier 20190319_nanos_newinfo_1_05-abstract
Title New Treatments for Migraine
Creator Kathleen B. Digre, MD
Affiliation John A. Moran Eye Center, University of Utah School of Medicine
Subject Migraine; Calcitonin Gene-Related Peptide; CGRP Receptor Antagonists; CGRP Monoclonal Antibodies; Device Therapies For Migraine
Description Migraine is very common-more common than diabetes and asthma combined. It affects almost 20% of; women and 10% of men, and will make up a large number of people visiting a neuro-ophthalmology clinic. The World Health Organization has listed migraine in the top 10 most disabling conditions. Keeping up with advances in migraine pathophysiology and treatment is almost a full-time job, but every neuro-ophthalmologist must know about these new advances in treatment since individuals will be requesting medication or presenting with migraine in the neuro-ophthalmology clinic.
Date 2019-03
Language eng
Format application/pdf
Type Text
Source 2019 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2019: New Information I Should Know
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2019. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6gr1cmf
Setname ehsl_novel_nam
ID 1423179
Reference URL https://collections.lib.utah.edu/ark:/87278/s6gr1cmf
Back to Search Results